Markers of type I and III collagen turnover as indicators of growth velocity in very low birth weight infants

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 9, 2001, Pages 4299-4306

  Kajantie, E ^a   Dunkel, L ^a   Risteli, J ^c   Pohjavuori, M ^a   Andersson, S ^a,b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; MATRIX METALLOPROTEINASE; PROCOLLAGEN;

ARTICLE; CALORIC INTAKE; CLINICAL ARTICLE; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; GROWTH RATE; HUMAN; INFANT; MALE; NEWBORN; POSTNATAL GROWTH; PREDICTION; PRIORITY JOURNAL; PROTEIN INTAKE; VERY LOW BIRTH WEIGHT; WEIGHT GAIN;

EID: 0034853434     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.9.7869     Document Type: Article

References (27)

1. Weight in infancy and death from ischaemic heart disease
2. Knemometry and the assessment of growth in premature babies
3. Short-term measurements of linear growth in early life: Infant knemometry
4. Products of bone collagen metabolism
5. Collagen metabolism and growth in prepubertal children treated with inhaled steroids
6. Serum concentrations of type I procollagen propeptides as biochemical markers of growth velocity in healthy children and in children with growth disorders
7. Knemometry, urine cortisol excretion, and measures of the insulin-like growth factor axis and collagen turnover in children treated with inhaled glucocorticoids
8. Plasma concentrations of the carboxyterminal propeptide of type I procollagen (PICP) in preterm neonates from birth to term
9. Growth failure and altered body composition are established by one month of age in infants with bronchopulmonary dysplasia
10. New Finnish fetal growth curves
11. Repeated measures
12. Growth retardation after dexamethasone administration: Assessment by knemometry
13. Validation of a newly developed mini-knemometer for premature infants
14. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis
15. Markers of type I and type III collagen turnover, insulin-like growth factors and their binding proteins in cord plasma of small premature infants: Relationships with fetal growth, gestational age, preeclampsia, and antenatal glucocorticoid treatment
16. Bone and collagen markers in preterm infants: Relationship with growth and bone mineral content over the first 10 weeks of life
17. Immunochemical characterization of the assay for the carboxyterminal telopeptide of human type I collagen (ICTP). Loss of antigenicity by treatment with cathepsin K
18. Serum levels of the pyridinoline crosslinked carboxyterminal telopeptide of type I collagen (ICTP) and osteocalcin in rachitic children in Nigeria
19. Determination of bone markers in pycnodysostosis: Effect of cathepsin K deficiency on bone matrix degradation
20. Serial serum C-reactive protein levels in the diagnosis of neonatal infection
21. Markers of collagen metabolism and insulin-like growth factor binding protein-1 in term infants
22. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants
23. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants
24. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants
25. Bone mineralisation in ex-preterm infants aged 8 years
26. Bone mineral metabolism in the micropremie
27. Randomised controlled trial of an aggressive nutritional regimen in sick very-low-birth-weight infants